Medicare Enrolled
Dr. Pramern Sriratana, M.D.
Optician · Normal, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sriratana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sriratana?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sriratana
Dr. Pramern Sriratana is an optician specialist in Normal, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sriratana performed 272,177 Medicare services across 6,769 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sriratana received a total of $14,644 from 60 pharmaceutical and/or device companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sriratana is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in IL
$14,644 industry payments
Medicare Practice Summary
Medicare Utilization ↗272,177
Medicare services
Top 0% in IL for optician
6,769
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~13,609 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
92,250 | $1 | $2 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
54,240 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 31,800 | $18 | $30 |
| Pembrolizumab injection (Keytruda) | 12,800 | $43 | $75 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
12,380 | $6 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
10,500 | $0 | $3 |
| Paclitaxel chemotherapy injection | 10,272 | $0 | $2 |
| Injection, docetaxel, 1 mg | 7,890 | $1 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
7,765 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 4,030 | $1 | $35 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,976 | $8 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,766 | $8 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,298 | $64 | $175 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,248 | $10 | $55 |
| Injection, granisetron hydrochloride, 100 mcg | 1,850 | $0 | $4 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,785 | $11 | $140 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,498 | $6 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,131 | $10 | $80 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
948 | $107 | $500 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
704 | $96 | $440 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
617 | $9 | $30 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
561 | $2 | $10 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
507 | $0 | $4 |
| Iron level test | 373 | $6 | $40 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
370 | $9 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
364 | $93 | $250 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
327 | $2 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
326 | $21 | $190 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
323 | $13 | $50 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
295 | $10 | $220 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
294 | $35 | $60 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
262 | $1 | $20 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
245 | $16 | $60 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
243 | $45 | $240 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 243 | $130 | $1,000 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
240 | $49 | $220 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
238 | $1 | $7 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
234 | $9 | $30 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
228 | $24 | $140 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
210 | $62 | $200 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
193 | $1 | $20 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 191 | $20 | $60 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
190 | $1 | $20 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
189 | $53 | $100 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
180 | $5 | $30 |
| PSA test (prostate cancer screening) | 178 | $18 | $50 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
176 | $53 | $150 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
174 | $0 | $10 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
139 | $1 | $6 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
138 | $8 | $100 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
133 | $13 | $140 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
129 | $7 | $25 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
121 | $20 | $210 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
120 | $2 | $20 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
119 | $24 | $277 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
118 | $6 | $25 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
117 | $4 | $30 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
107 | $27 | $210 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
75 | $81 | $260 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
73 | $5 | $15 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
71 | $19 | $55 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
70 | $4 | $25 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
68 | $17 | $60 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
64 | $130 | $600 |
| Injection, fentanyl citrate, 0.1 mg | 64 | $1 | $10 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
63 | $38 | $150 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
62 | $15 | $140 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
56 | $17 | $30 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
52 | $8 | $40 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 47 | $14 | $25 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
35 | $4 | $40 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
19 | $19 | $38 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
15 | $5 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.7% high complexity
58.8% medium
6.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,644
Total received (2018-2024)
Avg $2,092/year across 7 years
Top 6% in IL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
685
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,237 (83.6%)
Other
Charitable contributions, space rental, and other categories
$1,372 (9.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,035 (7.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,388
2023
$3,032
2022
$2,847
2021
$1,679
2020
$692
2019
$1,170
2018
$835
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,372
Janssen Biotech, Inc.
$651
AstraZeneca Pharmaceuticals LP
$402
Merck Sharp & Dohme LLC
$354
Genentech USA, Inc.
$235
Astellas Pharma US Inc
$204
Daiichi Sankyo Inc.
$149
PFIZER INC.
$130
GENZYME CORPORATION
$113
ABBVIE INC.
$107
SEAGEN INC.
$100
Eisai Inc.
$96
Gilead Sciences, Inc.
$82
JAZZ PHARMACEUTICALS INC.
$56
Incyte Corporation
$50
BeiGene USA, Inc.
$42
Tempus AI, Inc
$38
Exelixis Inc.
$36
Lilly USA, LLC
$35
Blueprint Medicines Corporation
$23
ADC Therapeutics America, Inc.
$23
ARRAY BIOPHARMA INC
$21
Genmab U.S., Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$19
Rigel Pharmaceuticals, Inc.
$14
TAIHO ONCOLOGY, INC.
$14
Top 3 companies account for 55.3% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$2,013
Novartis Pharmaceuticals Corporation
$1,856
Janssen Biotech, Inc.
$1,721
AstraZeneca Pharmaceuticals LP
$1,527
Merck Sharp & Dohme LLC
$931
PFIZER INC.
$534
E.R. Squibb & Sons, L.L.C.
$477
Daiichi Sankyo Inc.
$437
Lilly USA, LLC
$393
Merck Sharp & Dohme Corporation
$359
ABBVIE INC.
$352
Astellas Pharma US Inc
$349
Celgene Corporation
$308
GENZYME CORPORATION
$286
Amgen Inc.
$248
Gilead Sciences, Inc.
$234
Eisai Inc.
$230
Incyte Corporation
$147
NOVARTIS PHARMACEUTICALS CORPORATION
$138
Alexion Pharmaceuticals, Inc.
$132
BeiGene USA, Inc.
$120
Seagen Inc.
$105
GlaxoSmithKline, LLC.
$103
SEAGEN INC.
$100
AbbVie Inc.
$95
Progenics Pharmaceuticals, Inc.
$93
Regeneron Healthcare Solutions, Inc.
$87
Ipsen Biopharmaceuticals, Inc
$80
ARRAY BIOPHARMA INC
$73
TESARO, Inc.
$72
ADC Therapeutics America, Inc.
$63
Pharmacyclics LLC, an AbbVie Company
$62
Exelixis Inc.
$58
JAZZ PHARMACEUTICALS INC.
$56
Foundation Medicine, Inc.
$55
AVEO Pharmaceuticals, Inc.
$54
TAIHO ONCOLOGY, INC.
$49
Janssen Pharmaceuticals, Inc
$49
EISAI INC.
$47
Genmab U.S., Inc.
$42
Clovis Oncology, Inc.
$38
Tempus AI, Inc
$38
Mirati Therapeutics, Inc.
$37
Pharmacyclics LLC, An AbbVie Company
$36
Agios Pharmaceuticals, Inc.
$36
SOBI, INC
$33
Sobi, Inc
$27
Rigel Pharmaceuticals, Inc.
$27
Karyopharm Therapeutics Inc.
$26
Bayer HealthCare Pharmaceuticals Inc.
$26
Blueprint Medicines Corporation
$23
Epizyme, Inc.,
$23
Aveo Pharmaceuticals, Inc.
$22
Jazz Pharmaceuticals Inc.
$21
AbbVie, Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$19
G1 Therapeutics, Inc.
$18
Puma Biotechnology, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$14
Acrotech Biopharma LLC
$12
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Columvi · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · Erivedge · Erleada · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · IRESSA · Imbruvica · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · NERLYNX · Nerlynx · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PIQRAY · PLUVICTO · POLIVY · PROMACTA · PYLARIFY · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · REBLOZYL · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for optician in IL.
Geographic Context
Opticians within 10 mi
26
Per 100K population
15.2
County median income
$78,329
Nearest hospital
CARLE BROMENN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sriratana is a mixed practice specialist, with above-average Medicare volume (top 0% in IL), with low-engagement industry engagement in the top 6% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sriratana experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Sriratana performed 92,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sriratana receive payments from pharmaceutical companies?
Yes. Dr. Sriratana received a total of $14,644 from 60 companies across 685 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sriratana's costs compare to other opticians in Normal?
Dr. Sriratana's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sriratana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Normal
Browse opticians in Normal ranked by procedure volume and transparency data.
Highest volume
Top Opticians in IL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in IL
Which IL opticians receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology